bpc-157 fda warning 2025 october moves to Category 1 by…? Predictions & Odds 2026 FDA Advisory Committee Recommends Adding

Non-reversible side effects to the heart, joints, and liver may occur due to abnormal growth

The cancelled 2015 Phase I trial (NCT02637284) was almost certainly abandoned for this reason rather than buried by a regulator

Acetyl Tetrapeptide-3 Mechanism: This peptide strengthens the extracellular matrix around hair follicles, improving hair anchoring and reducing shedding

For 2 mg dose: 2 / 2 x 100 = 100 units 10 mg vial + 5 mL water = 2 mg/mL

The mechanisms likely involve a combination of its anti-inflammatory properties and its core angiogenic action, which improves blood flow to the injured site and supports the survival of salvageable neurons

2019 Both peptides demonstrate anti-inflammatory properties through distinct mechanisms, creating a more controlled healing environment